A detailed history of Jpmorgan Chase & CO transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 748 shares of SNSE stock, worth $388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
748
Previous 668 11.98%
Holding current value
$388
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.59 - $1.84 $47 - $147
80 Added 11.98%
748 $0
Q4 2022

Feb 13, 2023

SELL
$1.33 - $1.74 $1,389 - $1,818
-1,045 Reduced 61.0%
668 $1,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $2.24 $638 - $922
412 Added 31.67%
1,713 $3,000
Q2 2022

Aug 11, 2022

SELL
$1.49 - $2.3 $231,045 - $356,647
-155,064 Reduced 99.17%
1,301 $3,000
Q1 2022

May 11, 2022

SELL
$2.22 - $6.07 $7,576 - $20,716
-3,413 Reduced 2.14%
156,365 $361,000
Q4 2021

Feb 10, 2022

SELL
$4.85 - $10.48 $46,375 - $100,209
-9,562 Reduced 5.65%
159,778 $926,000
Q3 2021

Nov 12, 2021

BUY
$6.89 - $11.99 $1.17 Million - $2.03 Million
169,340 New
169,340 $1.78 Million

Others Institutions Holding SNSE

About Sensei Biotherapeutics, Inc.


  • Ticker SNSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,720,300
  • Market Cap $16M
  • Description
  • Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...
More about SNSE
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.